연구동향 분석

In Vivo Selection of Pan-Drug Resistant Acinetobacter baumannii during Antibiotic Treatment

김윤정 정석훈 배일권 용동은 이경원 2015년

논문상세정보
인용/피인용
' In Vivo Selection of Pan-Drug Resistant Acinetobacter baumannii during Antibiotic Treatment' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • 의학
  • acinetobacter baumannii
  • arma gene
  • colistin
  • lipida
  • pmrb gene
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
7,632 0

0.0%

' In Vivo Selection of Pan-Drug Resistant Acinetobacter baumannii during Antibiotic Treatment' 의 참고문헌

  • The pmrCAB operon mediates polymyxin resistance in Acinetobacter baumannii ATCC 17978 and clinical isolates through phosphoethanolamine modification of lipid A
    Arroyo LA Antimicrob Agents Chemother 2011 : 3743 ~ 3751
  • The pmrCAB operon mediates polymyxin resistance in Acinetobacter baumannii ATCC 17978 and clinical isolates through phosphoethanolamine modification of lipid A
    Arroyo LA Antimicrob Agents Chemother 55 3743-3751 [2011]
  • The Salmonella PmrAB regulon: lipopolysaccharide modifications, antimicrobial peptide resistance and more
    Gunn JS Trends Microbiol 16 : 284 ~ 290 [2008]
  • The Salmonella PmrAB regulon: lipopolysaccharide modifications, antimicrobial peptide resistance and more
    Gunn JS Trends Microbiol 16 284-290 [2008]
  • Spread and genetic characterization of ST137 and ST138 multidrug-resistant Acinetobacter baumannii isolated from a tertiary hospital in Korea
    Cho HH Ann Clin Lab Sci 43 : 145 ~ 150 [2013]
  • Spread and genetic characterization of ST137 and ST138 multidrug-resistant Acinetobacter baumannii isolated from a tertiary hospital in Korea
    Cho HH Ann Clin Lab Sci 43 145-150 [2013]
  • Sequencing of the rpoB gene and flanking spacers for molecular identification of Acinetobacter species
    La Scola B J Clin Microbiol 44 : 827 ~ 832 [2006]
  • Sequencing of the rpoB gene and flanking spacers for molecular identification of Acinetobacter species
    La Scola B J Clin Microbiol 44 827-832 [2006]
  • Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system
    Adams MD Antimicrob Agents Chemother 53 : 3628 ~ 3634 [2009]
  • Resistance to colistin in Acinetobacter baumannii associated with mutations in the PmrAB two-component system
    Adams MD Antimicrob Agents Chemother 53 3628-3634 [2009]
  • Rapid isolation method for lipopolysaccharide and lipid A from gram-negative bacteria
    Yi EC Analyst 125 : 651 ~ 656 [2000]
  • Rapid isolation method for lipopolysaccharide and lipid A from gram-negative bacteria
    Yi EC Analyst 125 651-656 [2000]
  • Quinoloneresistance mutations in the topoisomerase IV parC gene of Acinetobacter baumannii
    Vila J J Antimicrob Chemother 39 757-762 [1997]
  • Quinolone-resistance mutations in the topoisomerase IV parC gene of Acinetobacter baumannii
    Vila J J Antimicrob Chemother 39 : 757 ~ 762 [1997]
  • PmrA-PmrB-regulated genes necessary for 4-aminoarabinose lipid A modification and polymyxin resistance
    Gunn JS Mol Microbiol 27 : 1171 ~ 1182 [1998]
  • PmrA-PmrB-regulated genes necessary for 4-aminoarabinose lipid A modification and polymyxin resistance
    Gunn JS Mol Microbiol 27 1171-1182 [1998]
  • Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system
    Beceiro A Antimicrob Agents Chemother 55 : 3370 ~ 3379 [2011]
  • Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system
    Beceiro A Antimicrob Agents Chemother 55 3370-3379 [2011]
  • Performance standards for antimicrobial susceptibility testing: twenty-second informational supplement, M100-S22
    Clinical and Laboratory Standards Institute Clinical and Laboratory Standards Institute [2012]
  • Nosocomial outbreak of infection with pan-drug-resistant Acinetobacter baumannii in a tertiary care university hospital
    Valencia R Infect Control Hosp Epidemiol 30 : 257 ~ 263 [2009]
  • Nosocomial outbreak of infection with pan-drug-resistant Acinetobacter baumannii in a tertiary care university hospital
    Valencia R Infect Control Hosp Epidemiol 30 257-263 [2009]
  • Nosocomial outbreak of infection with multidrug-resistant Acinetobacter baumannii in a medical center in Taiwan
    Chang HL Infect Control Hosp Epidemiol 30 : 34 ~ 38 [2009]
  • Nosocomial outbreak of infection with multidrug-resistant Acinetobacter baumannii in a medical center in Taiwan
    Chang HL Infect Control Hosp Epidemiol 30 34-38 [2009]
  • Mutation in the gyrA gene of quinolone-resistant clinical isolates of Acinetobacter baumannii
    Vila J Antimicrob Agents Chemother 39 : 1201 ~ 1203 [1995]
  • Mutation in the gyrA gene of quinolone-resistant clinical isolates of Acinetobacter baumannii
    Vila J Antimicrob Agents Chemother 39 1201-1203 [1995]
  • Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp
    Woodford N Int J Antimicrob Agents 27 : 351 ~ 353 [2006]
  • Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp
    Woodford N Int J Antimicrob Agents 27 351-353 [2006]
  • Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
    Magiorakos AP Clin Microbiol Infect 18 : 268 ~ 281 [2012]
  • Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
    Magiorakos AP Clin Microbiol Infect 18 268-281 [2012]
  • Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance
    Gordon NC Int J Antimicrob Agents 35 : 219 ~ 226 [2010]
  • Multidrug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance
    Gordon NC Int J Antimicrob Agents 35 219-226 [2010]
  • Multidrug-Resistant Acinetobacter spp.: Increasingly Problematic Nosocomial Pathogens
    이경원 Yonsei Medical Journal 52 (6) : 879 ~ 891 [2011]
  • Multidrug-Resistant Acinetobacter spp.: Increasingly Problematic Nosocomial Pathogens
    이경원 Yonsei Medical Journal 52 6 879-891 [2011]
  • Molecular epidemiology of carbapenem-non-susceptible Acinetobacter baumannii in Japan
    Endo S J Antimicrob Chemother 67 : 1623 ~ 1626 [2012]
  • Molecular epidemiology of carbapenem-non-susceptible Acinetobacter baumannii in Japan
    Endo S J Antimicrob Chemother 67 1623-1626 [2012]
  • Lipid A modifications in polymyxin-resistant Salmonella typhimurium:PMRA-dependent 4-amino-4-deoxy-L-arabinose, and phosphoethanolamine incorporation
    Zhou Z J Biol Chem 276 : 43111 ~ 43121 [2001]
  • Lipid A modifications in polymyxin-resistant Salmonella typhimurium:PMRA-dependent 4-amino-4-deoxy-L-arabinose, and phosphoethanolamine incorporation
    Zhou Z J Biol Chem 276 43111-43121 [2001]
  • Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis:criteria for bacterial strain typing
    Tenover FC J Clin Microbiol 33 : 2233 ~ 2239 [1995]
  • Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing
    Tenover FC J Clin Microbiol 33 2233-2239 [1995]
  • In vivo emergence of colistin resistance in Acinetobacter baumannii clinical isolates of sequence type 357 during colistin treatment
    Kim Y Diagn Microbiol Infect Dis 79 : 362 ~ 366 [2014]
  • In vivo emergence of colistin resistance in Acinetobacter baumannii clinical isolates of sequence type 357 during colistin treatment
    Kim Y Diagn Microbiol Infect Dis 79 362-366 [2014]
  • Genetic basis of resistance to aminoglycosides in Acinetobacter spp. and spread of armA in Acinetobacter baumannii sequence group 1 in Korean hospitals
    Cho YJ Diagn Microbiol Infect Dis 64 : 185 ~ 190 [2009]
  • Genetic basis of resistance to aminoglycosides in Acinetobacter spp. and spread of armA in Acinetobacter baumannii sequence group 1 in Korean hospitals
    Cho YJ Diagn Microbiol Infect Dis 64 185-190 [2009]
  • Genetic basis of multidrug resistance in Acinetobacter clinical isolates in Taiwan
    Lin YC Antimicrob Agents Chemother 54 : 2078 ~ 2084 [2010]
  • Genetic basis of multidrug resistance in Acinetobacter clinical isolates in Taiwan
    Lin YC Antimicrob Agents Chemother 54 2078-2084 [2010]
  • Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii
    Bartual SG J Clin Microbiol 43 : 4382 ~ 4390 [2005]
  • Development of a multilocus sequence typing scheme for characterization of clinical isolates of Acinetobacter baumannii
    Bartual SG J Clin Microbiol 43 4382-4390 [2005]
  • Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies
    Cai Y J Antimicrob Chemother 67 : 1607 ~ 1615 [2012]
  • Colistin resistance of Acinetobacter baumannii: clinical reports, mechanisms and antimicrobial strategies
    Cai Y J Antimicrob Chemother 67 1607-1615 [2012]
  • Colistin resistance in a clinical Acinetobacter baumannii strain appearing after colistin treatment: effect on virulence and bacterial fitness
    López-Rojas R Antimicrob Agents Chemother 57 : 4587 ~ 4589 [2013]
  • Colistin resistance in a clinical Acinetobacter baumannii strain appearing after colistin treatment: effect on virulence and bacterial fitness
    López-Rojas R Antimicrob Agents Chemother 57 4587-4589 [2013]
  • Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production
    Moffatt JH Antimicrob Agents Chemother 54 : 4971 ~ 4977 [2010]
  • Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production
    Moffatt JH Antimicrob Agents Chemother 54 4971-4977 [2010]
  • Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies
    Petrosillo N Clin Microbiol Infect 14 : 816 ~ 827 [2008]
  • Colistin monotherapy vs. combination therapy: evidence from microbiological, animal and clinical studies
    Petrosillo N Clin Microbiol Infect 14 816-827 [2008]
  • Clonal diversity of Acinetobacter baumannii clinical isolates revealed by a snapshot study
    Wang X BMC Microbiol 13 : 234 ~ [2013]
  • Clonal diversity of Acinetobacter baumannii clinical isolates revealed by a snapshot study
    Wang X BMC Microbiol 13 234- [2013]
  • Carbapenem-nonsusceptible Acinetobacter baumannii of sequence type 92 or its single-locus variants with a G428T substitution in zone 2 of the rpoB gene
    Lee Y J Antimicrob Chemother 66 : 66 ~ 72 [2011]
  • Carbapenem-non-susceptible Acinetobacter baumannii of sequence type 92 or its single-locus variants with a G428T substitution in zone 2 of the rpoB gene
    Lee Y J Antimicrob Chemother 66 66-72 [2011]
  • Activities of vancomycin-containing regimens against colistin-resistant Acinetobacter baumannii clinical strains
    O’Hara JA Antimicrob Agents Chemother 57 : 2103 ~ 2108 [2013]
  • Activities of vancomycin-containing regimens against colistin-resistant Acinetobacter baumannii clinical strains
    O’Hara JA Antimicrob Agents Chemother 57 2103-2108 [2013]
  • Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options
    Maragakis LL Clin Infect Dis 46 : 1254 ~ 1263 [2008]
  • Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options
    Maragakis LL Clin Infect Dis 46 1254-1263 [2008]
  • Acinetobacter baumannii resistant to colistin alters its antibiotic resistance profile: a case report from Spain
    López-Rojas R J Infect Dis 204 : 1147 ~ 1148 [2011]
  • Acinetobacter baumannii resistant to colistin alters its antibiotic resistance profile: a case report from Spain
    López-Rojas R J Infect Dis 204 1147-1148 [2011]